Longitudinal inter‐ and intra‐individual human brain metabolic quantification over 3 years with proton MR spectroscopy at 3 T
暂无分享,去创建一个
Oded Gonen | James S Babb | J. Babb | O. Gonen | I. Kirov | Ivan I Kirov | Ilena C George | Nissa N. Perry | Nikhil Jayawickrama | Nissa N Perry | N. Perry | I. George | Nikhil Jayawickrama
[1] Arend Heerschap,et al. Short echo time 1H MRSI of the human brain at 3T with adiabatic slice‐selective refocusing pulses; reproducibility and variance in a dual center setting , 2010, Journal of magnetic resonance imaging : JMRI.
[2] W M Brooks,et al. Reproducibility of 1H‐MRS in vivo , 1999, Magnetic resonance in medicine.
[3] David H. Miller,et al. Biomarkers and surrogate outcomes in neurodegenerative disease: Lessons from multiple sclerosis , 2004, NeuroRX.
[4] Karl J. Friston,et al. Voxel-Based Morphometry—The Methods , 2000, NeuroImage.
[5] David H. Miller,et al. Reproducibility of in vivo metabolite quantification with proton magnetic resonance spectroscopic imaging , 2002, Journal of magnetic resonance imaging : JMRI.
[6] B. Mueller,et al. Proton echo‐planar spectroscopic imaging of J‐coupled resonances in human brain at 3 and 4 Tesla , 2007, Magnetic resonance in medicine.
[7] V. Calhoun,et al. Test‐retest reliability and reproducibility of short‐echo‐time spectroscopic imaging of human brain at 3T , 2011, Magnetic resonance in medicine.
[8] Robert E. Lenkinski,et al. Recent advances in magnetic resonance neurospectroscopy , 2007, Neurotherapeutics.
[9] Gadi Goelman,et al. Optimizing the efficiency of high‐field multivoxel spectroscopic imaging by multiplexing in space and time , 2006, Magnetic resonance in medicine.
[10] Oded Gonen,et al. Reproducibility of 3D proton spectroscopy in the human brain , 2002, Magnetic resonance in medicine.
[11] Daniel J Blezek,et al. Automatic repositioning of single voxels in longitudinal 1H MRS studies , 2005, NMR in biomedicine.
[12] P M Matthews,et al. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies , 2007, Neurology.
[13] Harald Hampel,et al. A multicenter reproducibility study of single-voxel 1H-MRS of the medial temporal lobe , 2006, European Radiology.
[14] H. Rusinek,et al. MR spectroscopy indicates diffuse multiple sclerosis activity during remission , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[15] A. A. Maudsley,et al. Reproducibility of serial whole‐brain MR Spectroscopic Imaging , 2009, NMR in biomedicine.
[16] Oded Gonen,et al. Diffusely elevated cerebral choline and creatine in relapsing‐remitting multiple sclerosis , 2003, Magnetic resonance in medicine.
[17] Oded Gonen,et al. Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T , 2008, Magnetic resonance in medicine.
[18] O. Gonen,et al. SNR versus resolution in 3D 1H MRS of the human brain at high magnetic fields , 2001, Magnetic resonance in medicine.
[19] Saadallah Ramadan,et al. Neurospectroscopy: the past, present and future. , 2010, Chemical reviews.
[20] V. Govindaraju,et al. Automated spectral analysis III: Application to in Vivo proton MR Spectroscopy and spectroscopic imaging , 1998, Magnetic resonance in medicine.
[21] P. Barker. Clinical MR Neuroimaging: Fundamentals of MR spectroscopy , 2004 .
[22] Jürgen Gieseke,et al. 1H metabolite relaxation times at 3.0 tesla: Measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation , 2004, Journal of magnetic resonance imaging : JMRI.
[23] Chris Boesch,et al. Integrated data acquisition and processing to determine metabolite contents, relaxation times, and macromolecule baseline in single examinations of individual subjects , 2005, Magnetic resonance in medicine.
[24] Regula S Briellmann,et al. Physiologic variability of single-voxel proton MR spectroscopic measurements at 3T. , 2005, AJNR. American journal of neuroradiology.